Integrated Wealth Concepts LLC Vertex Pharmaceuticals Inc Transaction History

Integrated Wealth Concepts LLC

$7.83 Billion
Q3 2024

A detailed history of Integrated Wealth Concepts LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 5,109 shares of VRTX stock, worth $2.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,109

Previous 3,337 53.1%

Holding current value

$2.09 Million

Previous $1.56 Million 51.92%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $815,120 - $896,242	1,772 Added 53.1%	5,109 $2.38 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $62,456 - $77,199	159 Added 5.0%	3,337 $1.56 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $115,376 - $126,240	283 Added 9.78%	3,178 $1.33 Million
Q3 2023 Nov 15, 2023	SELL	$338.18 - $362.46 $5,072 - $5,436	-15 Reduced 0.52%	2,895 $1.01 Million
Q2 2023 Aug 15, 2023	BUY	$314.42 - $351.91 $288,951 - $323,405	919 Added 46.16%	2,910 $1.02 Million
Q1 2023 May 03, 2023	BUY	$283.23 - $323.1 $563,910 - $643,292	1,991 New	1,991 $627,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $13,965 - $15,582	-51 Reduced 6.51%	733 $212,000
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $42,762 - $53,244	-182 Reduced 18.84%	784 $221,000
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $63,547 - $74,898	-287 Reduced 22.91%	966 $252,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $20,179 - $25,473	-114 Reduced 8.34%	1,253 $275,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $112,824 - $126,259	-622 Reduced 31.27%	1,367 $248,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $42,185 - $49,747	-225 Reduced 10.16%	1,989 $401,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $32,088 - $37,403	155 Added 7.53%	2,214 $476,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $141,387 - $188,569	-683 Reduced 24.91%	2,059 $487,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $164,127 - $194,590	642 Added 30.57%	2,742 $746,000
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $1,803 - $2,366	8 Added 0.38%	2,100 $610,000
Q1 2020 May 18, 2020	BUY	$199.77 - $247.81 $73,115 - $90,698	366 Added 21.21%	2,092 $498,000
Q4 2019 Feb 20, 2020	SELL	$166.71 - $223.91 $8,335 - $11,195	-50 Reduced 2.82%	1,726 $378,000
Q3 2019 Nov 15, 2019	BUY	$166.23 - $187.09 $10,971 - $12,347	66 Added 3.86%	1,776 $301,000
Q2 2019 Aug 15, 2019	BUY	$164.61 - $190.37 $85,432 - $98,802	519 Added 43.58%	1,710 $314,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $195,002 - $231,887	1,191 New	1,191 $219,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.

Account

Integrated Wealth Concepts LLC Vertex Pharmaceuticals Inc Transaction History